Antithrombotic therapy for stable coronary artery disease: the difficult quest for the holy balance.
Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, France; Université Paris-Descartes, France; INSERM U970, Paris, France nicolasdanchin@yahoo.fr.
Nicolas
N
Danchin
Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, France; Université Paris-Descartes, France; INSERM U970, Paris, France.
Etienne
E
Puymirat
Centre Hospitalier Universitaire Jean Minjoz, France; Université de Franche-Comté, France.
François
F
Schiele
D000925:Anticoagulants / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D013988:Ticlopidine / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine